Since 2006, Medichem’s strategy has included the development of a vertically integrated organization to oversee every facet of the development chain of our value-added generics. From research combined with intellectual property strategy and agile regulatory guidance, to quality-driven manufacturing and the ultimate nimble supply chain support, our organization enables our customers to be first to market with a reliable and quality product.
OUR FDF IN NUMBERS
830
EU marketing authorizations
6
FDFs available
13
FDFs in pipeline
2
ANDAs filed at FDA
1
ANDA approved at FDA
FINISHED DOSAGE FORMS
EXPONENTIAL GROWTH
Over the past two decades, Medichem has successfully developed and launched a broad portfolio of dosage forms, while developing a particular expertise in sterile and solid oral dosage forms.
SOLID ORAL DOSAGE FORMS
- Capsules
- Sprinkle capsules
- Tablets
- Film-coated tablets
STERILE FORMS
- Ampoule blow-fill-seal
- Powder for solution for injection or infusion
- Pre-filled syringe
- Solution for inhalation, injection or infusion
SOLUTIONS
- Oral Solution in bottle
cutting-edge technologies employed:
PELLETS BY EXTRUSION
PELLETS BY LAYERING
HOT MELT EXTRUSION
LYOPHILIZATION (FREEZE DRYING)
WET OR DRY GRANULATION
FDF PRODUCT LIST
Over the past few years, Medichem has focused on developing and manufacturing Finished Dosage Forms (FDFs) with particular technological barriers, creating value-added products aimed at the following therapeutic areas:
Should you need more information on our products under development, please reach us at bd@medichem.es
